Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET/CT in cancer patients

被引:0
作者
Frederik L. Giesel
Clemens Kratochwil
Joel Schlittenhardt
Katharina Dendl
Matthias Eiber
Fabian Staudinger
Lukas Kessler
Wolfgang P. Fendler
Thomas Lindner
Stefan A. Koerber
Jens Cardinale
David Sennung
Manuel Roehrich
Juergen Debus
Mike Sathekge
Uwe Haberkorn
Jeremie Calais
Sebastian Serfling
Andreas L. Buck
机构
[1] University Hospital Duesseldorf,Department of Nuclear Medicine
[2] University Hospital Heidelberg,Department of Nuclear Medicine
[3] Technical University of Munich,Department of Nuclear Medicine, Klinikum rechts der Isar
[4] University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen,Department of Nuclear Medicine
[5] National Center for Tumor diseases (NCT),Clinical Cooperation Unit Radiation Oncology
[6] German Cancer Research Center (DKFZ),Department of Radiation Oncology
[7] Heidelberg Institute of Radiation Oncology (HIRO),Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology
[8] University Hospital Heidelberg,Department of Nuclear Medicine
[9] University of California at Los Angeles,Clinical Cooperation Unit Nuclear Medicine
[10] Heidelberg Ion-Beam Therapy Center (HIT),Translational Lung Research Center Heidelberg (TLRC)
[11] University of Pretoria and Steve Biko Academic Hospital,Department of Nuclear Medicine
[12] German Cancer Research Center (DKFZ),undefined
[13] German Center for Lung Research (DZL),undefined
[14] University Hospital Würzburg,undefined
[15] Comprehensive Cancer Center Mainfranken,undefined
来源
European Journal of Nuclear Medicine and Molecular Imaging | 2021年 / 48卷
关键词
FAPI PET/CT; FDG PET/CT; Cancer-associated fibroblast; Various cancer diseases;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:4377 / 4385
页数:8
相关论文
共 86 条
[1]  
Hanahan D(2011)Hallmarks of cancer: the next generation Cell. 144 646-674
[2]  
Weinberg RA(2011)18F-FDG PET/CT imaging in oncology Ann Saudi Med 31 3-13
[3]  
Almuhaideb A(2015)Appropriateness criteria of FDG PET/CT in oncology Indian J Radiol Imaging 25 88-101
[4]  
Papathanasiou N(2018)Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein J Nucl Med 59 1415-1422
[5]  
Bomanji J(2018)A tumor-imaging method targeting cancer-associated fibroblasts J Nucl Med 59 1423-1429
[6]  
Agrawal A(2016)Carcinoma-associated fibroblasts: orchestrating the composition of malignancy Genes Dev 30 1002-1019
[7]  
Rangarajan V(2019)Cancer associated fibroblasts: is the force the path to the dark side? Curr Opin Cell Biol 56 71-79
[8]  
Lindner T(2014)Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy Proteomics Clin Appl 8 454-463
[9]  
Loktev A(2020)Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging Ann Rheum Dis 79 1485-1491
[10]  
Altmann A(2019)Targeting of activated fibroblasts for imaging and therapy EJNMMI Radiopharm Chem 4 16-1429